Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_210_библиотеки_им_акад_М_И_Перельмана
.pdf
321
125. Cheng, D.A review of a potential and promising probiotic candidate–
Akkermansia muciniphila / D. Cheng, M.Z. Xie // Journal of Applied Microbiology. –
2021. – Vol. 130, N 6. – P.1813–1822.
126. Cheung, K.P. Immunomodulation at epithelial sites by obesity and
metabolic disease / K.P. Cheung, K.R. Taylor, J.M. Jameson // Immunologic Research.
– 2012. – Vol. 52, N 3. – P.182–199.
127. Ciccocioppo, R. Letter: diarrhoea in obese patients–a new nosographic
entity? / R. Ciccocioppo, R.De Giorgio // Alimentary Pharmacology & Therapeutics. –
2020. – Vol. 51, N 3. – P.405.
128. Clinical and psychological responses to synbiotic supplementation in obese
or overweight adults: A randomized clinical trial / A. Hadi, M. Sepandi, W. Marx [et
al.] // Complementary Therapies in Medicine. – 2019. – Vol. 47 – P.102216.
129. Clinical practice guidelines for the perioperative nutrition, metabolic, and
nonsurgical support of patients undergoing bariatric procedures – 2019 update:
cosponsored by american association of clinical endocrinologists/american college of
endocrinology, the obesity society, american society for metabolic & bariatric surgery,
obesity medicine association, and american society of anesthesiologists – executive
summary / J.I. Mechanick, C. Apovian, S. Brethauer [et al.] // Endocrine Practice. –
2019. – Vol. 25, N 12. – P.1346–1359.
130. Clinical practice guidelines of the European Association for Endoscopic
Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO–EC, EASO and
ESPCOP / N.Di Lorenzo, S.A. Antoniou, R.L. Batterham [et al.] // Surgical Endoscopy.
– 2020. – Vol. 34, N 6. – P.2332–2358.
131. Comparative analysis of weight loss and resolution of comorbidities
between laparoscopic sleeve gastrectomy and Roux–en–Y gastric bypass: A systematic
review and meta–analysis based on 18 studies / Y. Han, Y. Jia, H. Wang [et al.] //
International Journal of Surgery (London, England). – 2020. – Vol. 76 – P.101–110.
132. Comparison of safety and effectiveness between laparoscopic mini–gastric
bypass and laparoscopic sleeve gastrectomy: A meta–analysis and systematic review /
https://t.me/med1917
322
F.–G. Wang, Z.–P. Yu, W.–M. Yan [et al.] // Medicine. – 2017. – Vol. 96 – N 50. –
P.e8924.
133. Complications of bariatric surgery: Presentation and emergency
management / R. Kassir, T. Debs, P. Blanc [et al.] // International Journal of Surgery
(London, England). – 2016. – Vol. 27. – Complications of bariatric surgery. – P.77–81.
134. Cortés, V.A. Pathophysiological connections between gallstone disease,
insulin resistance, and obesity / V.A. Cortés, F. Barrera, F. Nervi // Obesity Reviews. –
2020. – Vol. 21. – N 4. – P.e12983.
135. COX–2 induction by unconjugated bile acids involves reactive oxygen
species–mediated signalling pathways in Barrett’s oesophagus and oesophageal
adenocarcinoma / S. Song, S. Guha, K. Liu [et al.] // Gut. – 2007. – Vol. 56, N 11. –
P.1512–1521.
136. Crovesy, L. Profile of the gut microbiota of adults with obesity: a
systematic review / L. Crovesy, D. Masterson, E.L. Rosado // European Journal of
Clinical Nutrition. – 2020. – Vol. 74, N 9. – P.1251–1262.
137. CYP2C19 genotype is associated with symptomatic recurrence of GERD
during maintenance therapy with low–dose lansoprazole / T. Furuta, M. Sugimoto, C.
Kodaira [et al.] // European Journal of Clinical Pharmacology. – 2009. – Vol. 65, N 7. –
P.693–698.
138. De Bortoli, N. Weight Loss Is Truly Effective in Reducing Symptoms and
Proton Pump Inhibitor Use in Patients With Gastroesophageal Reflux Disease / N. De
Bortoli, S. Tolone, E.V. Savarino // Clinical Gastroenterology and Hepatology. – 2015.
– Vol. 13, N 11. – P.2023.
139. Decreased glucagon–like peptide–1 correlates with abdominal pain in
patients with constipation–predominant irritable bowel syndrome / Z.–Y. Li, N. Zhang,
S. Wen [et al.] // Clinics and Research in Hepatology and Gastroenterology. – 2017. –
Vol. 41, N 4. – P.459–465.
140. Defining comorbidity: implications for understanding health and health
services / J.M. Valderas, B. Starfield, B. Sibbald [et al.] // Annals of Family Medicine. –
2009. – Vol. 7, N 4. – P.357–363.
https://t.me/med1917
323
141. Definition of the Mediterranean Diet; a Literature Review / C. Davis, J.
Bryan, J. Hodgson, K. Murphy // Nutrients. – 2015. – Vol. 7, N 11. – P.9139–9153.
142. Delzenne, N.M. Modulation of the gut microbiota by nutrients with
prebiotic properties: consequences for host health in the context of obesity and
metabolic syndrome / N.M. Delzenne, A.M. Neyrinck, P.D. Cani // Microbial Cell
Factories. – 2011. – Vol. 10 Suppl 1 – P.S10.
143. Deprescribing versus continuation of chronic proton pump inhibitor use in
adults / T.A. Boghossian, F.J. Rashid, W. Thompson [et al.] // The Cochrane Database
of Systematic Reviews. – 2017. – Vol. 3. – P.CD011969.
144. Depression subtypes and obesity in adults: A systematic review and meta–
analysis / D.A. Silva, E.da S.F. Coutinho, L.O. Ferriani, M.C. Viana // Obesity
Reviews. – 2020. – Vol. 21, N 3. – P.e12966.
145. Development of the GerdQ, a tool for the diagnosis and management of
gastro–oesophageal reflux disease in primary care / R. Jones, O. Junghard, J. Dent [et
al.] // Alimentary Pharmacology & Therapeutics. – 2009. – Vol. 30, N 10. – P.1030–
1038.
146. Diet and effects of diet management on quality of life and symptoms in
patients with irritable bowel syndrome / H. Ostgaard, T. Hausken, D. Gundersen, M.
El–Salhy // Molecular Medicine Reports. – 2012. – Vol. 5, N 6. – P.1382–1390.
147. Differences between risk factors among irritable bowel syndrome subtypes
in Japanese adults / M. Kubo, Y. Fujiwara, M. Shiba [et al.] // Neurogastroenterology
and Motility. – 2011. – Vol. 23, N 3. – P.249–254.
148. Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?:
A Systematic Review and Meta–analysis / K.T.D. Yeung, N. Penney, L. Ashrafian [et
al.] // Annals of Surgery. – 2020. – Vol. 271, N 2. – P.257–265.
149. Drossman, D.A. Functional Gastrointestinal Disorders: History,
Pathophysiology, Clinical Features and Rome IV / D.A. Drossman // Gastroenterology.
– 2016. – P.S0016–5085(16)00223–7.
https://t.me/med1917
324
150. Drugs for improving esophageal mucosa defense: where are we now and
where are we going? / E. Savarino, P. Zentilin, E. Marabotto [et al.] // Annals of
Gastroenterology. – 2017. – Vol. 30, N 6. – P.585–591.
151. Dukowicz, A.C. Small intestinal bacterial overgrowth: a comprehensive
review / A.C. Dukowicz, B.E. Lacy, G.M. Levine // Gastroenterology & Hepatology. –
2007. – Vol. 3, N 2. – P.112–122.
152. Dynamic distribution of gallbladder microbiota in rabbit at different ages
and health states / Y. Xing, J. Liu, F. Lu [et al.] // PloS One. – 2019. – Vol. 14, N 2. –
P.e0211828.
153. Early major complications after bariatric surgery in the USA, 2003–2014: a
systematic review and meta–analysis / S.–H. Chang, N.L.B. Freeman, J.A. Lee [et al.] //
Obesity Reviews. – 2018. – Vol. 19, N 4. – P.529–537.
154. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese
Patients / J.R. Allegretti, Z. Kassam, B.H. Mullish [et al.] // Clinical Gastroenterology
and Hepatology. – 2020. – Vol. 18, N 4. – P.855–863.e2.
155. El–Serag, H. The association between obesity and GERD: a review of the
epidemiological evidence / H. El–Serag // Digestive Diseases and Sciences. – 2008. –
Vol. 53, N 9. – P.2307–2312.
156. Endoscopic assessment of oesophagitis: clinical and functional correlates
and further validation of the Los Angeles classification / L.R. Lundell, J. Dent, J.R.
Bennett [et al.] // Gut. – 1999. – Vol. 45, N 2. – P.172–180.
157. Epidemiology of esophageal cancer: update in global trends, etiology and
risk factors / D.J. Uhlenhopp, E.O. Then, T. Sunkara, V. Gaduputi // Clinical Journal of
Gastroenterology. – 2020. – Vol. 13, N 6. – P.1010–1021.
158. Epidemiology of functional diarrhea and comparison with diarrhea–
predominant irritable bowel syndrome: a population–based survey in China / Y.–F.
Zhao, X.–J. Guo, Z.–S. Zhang [et al.] // PloS One. – 2012. – Vol. 7, N 8. – P.e43749.
159. Epidemiology of multimorbidity and implications for health care, research,
and medical education: a cross–sectional study / K. Barnett, S.W. Mercer, M. Norbury
[et al.] // Lancet (London, England). – 2012. – Vol. 380, N 9836. – P.37–43.
https://t.me/med1917
325
160. Eslick, G.D. Gastrointestinal symptoms and obesity: a meta–analysis / G.D.
Eslick // Obesity Reviews. – 2012. – Vol. 13, N 5. – P.469–479.
161. European Guidelines for Obesity Management in Adults / V. Yumuk, C.
Tsigos, M. Fried [et al.] // Obesity Facts. – 2015. – Vol. 8, N 6. – P.402–424.
162. European Practical and Patient–Centred Guidelines for Adult Obesity
Management in Primary Care / D. Durrer Schutz, L. Busetto, D. Dicker [et al.] //
Obesity Facts. – 2019. – Vol. 12, N 1. – P.40–66.
163. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease /
R. Catanzaro, B. Cuffari, A. Italia, F. Marotta // World Journal of Gastroenterology. –
2016. – Vol. 22, N 34. – P.7660–7675.
164. Fecal microbiota transplant for treatment of Clostridium difficile infection
in immunocompromised patients / C.R. Kelly, C. Ihunnah, M. Fischer [et al.] // The
American Journal of Gastroenterology. – 2014. – Vol. 109, N 7. – P.1065–1071.
165. Feinle–Bisset, C. Dietary lipids and functional gastrointestinal disorders /
C. Feinle–Bisset, F. Azpiroz // The American Journal of Gastroenterology. – 2013. –
Vol. 108, N 5. – P.737–747.
166. Fock, K.M. Diet and exercise in management of obesity and overweight /
K.M. Fock, J. Khoo // Journal of Gastroenterology and Hepatology. – 2013. – Vol. 28
Suppl 4. – P.59–63.
167. Food and Gastroesophageal Reflux Disease / T. Surdea–Blaga, D.E.
Negrutiu, M. Palage, D.L. Dumitrascu // Current Medicinal Chemistry. – 2019. – Vol.
26, N 19. – P.3497–3511.
168. Frequency of small intestinal bacterial overgrowth in patients with irritable
bowel syndrome and chronic non–specific diarrhea / U.C. Ghoshal, S. Kumar, M.
Mehrotra [et al.] // Journal of Neurogastroenterology and Motility. – 2010. – Vol. 16, N
1. – P.40–46.
169. Functional dysbiosis within the gut microbiota of patients with
constipated–irritable bowel syndrome / C. Chassard, M. Dapoigny, K.P. Scott [et al.] //
Alimentary Pharmacology & Therapeutics. – 2012. – Vol. 35, N 7. – P.828–838.
https://t.me/med1917
326
170. Fung, T.C. Interactions between the microbiota, immune and nervous
systems in health and disease / T.C. Fung, C.A. Olson, E.Y. Hsiao // Nature
Neuroscience. – 2017. – Vol. 20, N 2. – P.145–155.
171. Gammadelta T cells are reduced and rendered unresponsive by
hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic
disease / K.R. Taylor, R.E. Mills, A.E. Costanzo, J.M. Jameson // PloS One. – 2010. –
Vol. 5, N 7. – P.e11422.
172. Gastroesophageal reflux in obese patients is not reduced by weight
reduction / A. Kjellin, S. Ramel, S. Rössner, K. Thor // Scandinavian Journal of
Gastroenterology. – 1996. – Vol. 31, N 11. – P.1047–1051.
173. GBD 2017 Gastro–oesophageal Reflux Disease Collaborators. The global,
regional, and national burden of gastro–oesophageal reflux disease in 195 countries and
territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study
2017 / GBD 2017 Gastro–oesophageal Reflux Disease Collaborators // The Lancet.
Gastroenterology & Hepatology. – 2020. – Vol. 5, N 6. – P.561–581.
174. GERD after Bariatric Surgery. Can We Expect Endoscopic Findings? / R.
Vilallonga, S. Sanchez–Cordero, N. Umpiérrez Mayor [et al.] // Medicina (Kaunas,
Lithuania). – 2021. – Vol. 57, N 5. – P.506.
175. GERD and obesity: is the autonomic nervous system the missing link? / N.
Devendran, N. Chauhan, D. Armstrong [et al.] // Critical Reviews in Biomedical
Engineering. – 2014. – Vol. 42, N 1. – P.17–24.
176. GERD outcome after bariatric surgery: A protocol for systematic review
and meta-analysis / A.–N. Elzouki, M.–A. Waheed, S. Suwileh [et al.] // Medicine. –
2020. – Vol. 99, N 19. – P.e19823.
177. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s
Esophagus / S.J. Thomas, L. Almers, J. Schneider [et al.] // Digestive Diseases and
Sciences. – 2016. – Vol. 61, N 1. – P.70–79.
178. Global epidemiology of nonalcoholic fatty liver disease–Meta–analytic
assessment of prevalence, incidence, and outcomes / Z.M. Younossi, A.B. Koenig, D.
Abdelatif [et al.] // Hepatology (Baltimore, Md.). – 2016. – Vol. 64, N 1. – P.73–84.
https://t.me/med1917
327
179. Global prevalence of, and risk factors for, gastro–oesophageal reflux
symptoms: a meta–analysis / L.H. Eusebi, R. Ratnakumaran, Y. Yuan [et al.] // Gut. –
2018. – Vol. 67, N 3. – P.430–440.
180. Global prevalence of irritable bowel syndrome according to Rome III or IV
criteria: a systematic review and meta–analysis / P. Oka, H. Parr, B. Barberio [et al.] //
The Lancet. Gastroenterology & Hepatology. – 2020. – Vol. 5, N 10. – P.908–917.
181. Glovaci D. Epidemiology of Diabetes Mellitus and Cardiovascular Disease
/ D. Glovaci, W. Fan, N.D. Wong // Current Cardiology Reports. – 2019. – Vol. 21, N
4. – P.21.
182. GLP–1: Molecular mechanisms and outcomes of a complex signaling
system / N.K. Smith, T.A. Hackett, A. Galli, C. R. Flynn // Neurochemistry
International. – 2019. – Vol. 128. – GLP–1. – P.94–105.
183. Goossens, G.H. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat
Distribution, and Adipose Tissue Function / G.H. Goossens // Obesity Facts. – 2017. –
Vol. 10, N 3. – P.207–215.
184. Green, M. Microbial Medicine: Prebiotic and Probiotic Functional Foods to
Target Obesity and Metabolic Syndrome / M. Green, K. Arora, S. Prakash //
International Journal of Molecular Sciences. – 2020. – Vol. 21, N 8. – P.E2890.
185. Green tea for weight loss and weight maintenance in overweight or obese
adults / T.M. Jurgens, A.M. Whelan, L. Killian [et al.] // The Cochrane Database of
Systematic Reviews. – 2012. – Vol. 12. – P.CD008650.
186. Greenway, F.L. Physiological adaptations to weight loss and factors
favouring weight regain / F.L. Greenway // International Journal of Obesity. – 2015. –
Vol. 39, N 8. – P.1188–1196.
187. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery
After Surgery (ERAS) Society Recommendations / A. Thorell, A.D. MacCormick, S.
Awad [et al.] // World Journal of Surgery. – 2016. – Vol. 40, N 9. – P.2065–2083.
188. Gupta, S. Asthma, GERD and Obesity: Triangle of Inflammation / S.
Gupta, R. Lodha, S.K. Kabra // Indian Journal of Pediatrics. – 2018. – Vol. 85, N 10. –
P.887–892.
https://t.me/med1917
328
189. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut
microbiota from diabetic humans / I. Liaqat, N.M. Ali, N. Arshad [et al.] // Brazilian
Journal of Biology. – 2021. – Vol. 83. – P.e242818.
190. Gut microbiota and diet in patients with different glucose tolerance / L.
Egshatyan, D. Kashtanova, A. Popenko [et al.] // Endocrine Connections. – 2016. – Vol.
5. – N 1. – P.1–9.
191. Gut microbiota and metabolic syndrome / P.–X. Wang, X.–R. Deng, C.–H.
Zhang, H.–J. Yuan // Chinese Medical Journal. – 2020. – Vol. 133, N 7. – P.808–816.
192. Gut microbiota phenotypes of obesity / M.A. Stanislawski, D. Dabelea,
L.A. Lange [et al.] // NPJ biofilms and microbiomes. – 2019. – Vol. 5, N 1. – P.18.
193. Gut Microbiota–Mediated Inflammation and Gut Permeability in Patients
with Obesity and Colorectal Cancer / L. Sánchez–Alcoholado, R. Ordóñez, A. Otero [et
al.] // International Journal of Molecular Sciences. – 2020. – Vol. 21, N 18. – P.E6782.
194. Gutschow, C.A. Barrett’s esophagus: what is the poison – alkaline, biliary
or acidic reflux? / C.A. Gutschow, W. Schröder, A.H. Hölscher // Diseases of the
Esophagus. – 2002. – Vol. 15, N 1. – P.5–9.
195. Harmonizing the metabolic syndrome: a joint interim statement of the
International Diabetes Federation Task Force on Epidemiology and Prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World Heart
Federation; International Atherosclerosis Society; and International Association for the
Study of Obesity / K.G.M.M. Alberti, R.H. Eckel, S.M. Grundy [et al.] // Circulation. –
2009. – Vol. 120, N 16. – P.1640–1645.
196. Haslam, D.W. Obesity / D.W. Haslam, W.P.T. James // Lancet (London,
England). – 2005. – Vol. 366, N 9492. – P.1197–1209.
197. Heartburn, Functional Dyspepsia, Anxiety/Depression, and Sleep
Disturbances Are Associated With Clinically Significant Belching / Y. Fujiwara, M.
Okuyama, Y. Nagami [et al.] // Journal of Neurogastroenterology and Motility. – 2021.
– Vol. 27, N 4. – P.581–587.
https://t.me/med1917
329
198. Hersoug, L.–G. Role of microbiota–derived lipopolysaccharide in adipose
tissue inflammation, adipocyte size and pyroptosis during obesity / L.–G. Hersoug, P.
Møller, S. Loft // Nutrition Research Reviews. – 2018. – Vol. 31, N 2. – P.153–163.
199. Heymsfield, S.B. Mechanisms, Pathophysiology, and Management of
Obesity / S.B. Heymsfield, T.A. Wadden // The New England Journal of Medicine. –
2017. – Vol. 376, N 3. – P.254–266.
200. Hiatal Hernia Repair during Laparoscopic Sleeve Gastrectomy: Systematic
Review and Meta–analysis on Gastroesophageal Reflux Disease symptoms changes / P.
Małczak, M. Pisarska–Adamczyk, P. Zarzycki [et al.] // Polski Przeglad Chirurgiczny. –
2021. – Vol. 93, N 5. – P.1–5.
201. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in
Irritable Bowel Syndrome / I.S. Vahora, N. Tsouklidis, R. Kumar [et al.] // Cureus. –
2020. – Vol. 12. N 8. – P.e9871.
202. How to best assess abdominal obesity / H. Fang, E. Berg, X. Cheng, W.
Shen // Current Opinion in Clinical Nutrition and Metabolic Care. – 2018. – Vol. 21, N
5. – P.360–365.
203. Human organ/tissue growth algorithms that include obese individuals and
black/white population organ weight similarities from autopsy data / J.F. Young, R.H.
Luecke, B.A. Pearce [et al.] // Journal of Toxicology and Environmental Health. Part A.
– 2009. – Vol. 72, N 8. – P.527–540.
204. Human originated bacteria, Lactobacillus rhamnosus PL60, produce
conjugated linoleic acid and show anti–obesity effects in diet–induced obese mice / H.–
Y. Lee, J.–H. Park, S.–H. Seok [et al.] // Biochimica Et Biophysica Acta. – 2006. – Vol.
1761, N 7. – P.736–744.
205. Impact of bacterial probiotics on obesity, diabetes and non–alcoholic fatty
liver disease related variables: a systematic review and meta–analysis of randomised
controlled trials / H. Koutnikova, B. Genser, M. Monteiro–Sepulveda [et al.] // BMJ
open. – 2019. – Vol. 9, N 3. – P.e017995.
206. Impact of outdoor nature–related activities on gut microbiota, fecal
serotonin, and perceived stress in preschool children: the Play&Grow randomized
https://t.me/med1917
330
controlled trial / T. Sobko, S. Liang, W.H.G. Cheng, H.M. Tun // Scientific Reports. –
2020. – Vol. 10, N 1. – P.21993.
207. Impact of psychological stress on irritable bowel syndrome / H.–Y. Qin,
C.–W. Cheng, X.–D. Tang, Z.–X. Bian // World Journal of Gastroenterology. – 2014. –
Vol. 20, N 39. – P.14126–14131.
208. Improvement in gastroesophageal reflux disease symptoms after various
bariatric procedures: review of the Bariatric Outcomes Longitudinal Database / P. K.
Pallati, A. Shaligram, V. K. Shostrom [et al.] // Surgery for Obesity and Related
Diseases. – 2014. – Vol. 10, N 3. – P.502–507.
209. Improvement of gastroesophageal reflux symptoms after standardized
laparoscopic sleeve gastrectomy / J. Daes, M.E. Jimenez, N. Said, R. Dennis // Obesity
Surgery. – 2014. – Vol. 24, N 4. – P.536–540.
210. Increased prevalence of gallstone disease and impaired gallbladder motility
in patients with Barrett’s esophagus / F. Izbéki, A.I. Rosztóczy, J.S. Yobuta [et al.] //
Digestive Diseases and Sciences. – 2008. – Vol. 53, N 8. – P.2268–2275.
211. Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French
Morbidly Obese Patients Candidate for Bariatric Surgery / A.S. Schneck, R. Anty, A.
Tran [et al.] // Obesity Surgery. – 2016. – Vol. 26, N 7. – P.1525–1530.
212. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive
function in the hyperammonemia rat / J. Luo, T. Wang, S. Liang [et al.] // Science
China. Life Sciences. – 2014. – Vol. 57, N 3. – P.327–335.
213. Insight into the prebiotic concept: lessons from an exploratory, double
blind intervention study with inulin–type fructans in obese women / E.M. Dewulf, P.D.
Cani, S.P. Claus [et al.] // Gut. – 2013. – Vol. 62. – Insight into the prebiotic concept. –
N 8, P.1112–1121.
214. Interactions between commensal bacteria and gut sensorimotor function in
health and disease / G. Barbara, V. Stanghellini, G. Brandi [et al.] // The American
Journal of Gastroenterology. – 2005. – Vol. 100, N 11. – P.2560–2568.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана